13 completed, 1 recruiting, 1 terminated, 1 withdrawn. 16 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 16 | Completed 13, Recruiting 1, Terminated 1, Withdrawn 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Dental Pain: new trials by email Literature Review of Dental Pain trials Research Report on Dental Pain
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of CYT-1010 in Healthy Volunteers and Participants With Acute Pain After Third Molar Extraction CYT-1010, Placebo - Acute Postoperative Pain, Dental Pain | Phase 1 / Phase 2 | Recruiting | Cytogel Pharma, LLC | 32 | 2026-09-25 | 2026-10-29 |
| A Study of Acetaminophen for Post Surgical Dental Pain Acetaminophen, Placebo - Pain, Postoperative, Dental Pain | Phase 2 | Completed | Nevakar, Inc. | 110 | 2019-04-25 | 2022-03-29 |
| The Impact of Minimally Invasive Restorative Techniques on Dental Pain in Pregnant Women Papacarie, Atraumatic Restorative Treatment - Dental Pain, Patient Satisfaction | Phase 2 | Completed | Nourhan M.Aly | 162 | 2019-01-10 | 2020-10-05 |
| Dental Pain Study of Analgesics in Patients Undergoing Molar Removal Pre-Op pregabalin, Pre-Op Placebo 1, Post-Op pregabalin - Dental Pain | Phase 2 | Completed | Nevakar, Inc. | 115 | 2018-06-15 | 2021-11-23 |
| Study of Acetaminophen (ACE) in Post-operative Dental Pain Acetaminophen (ACE) (1000 mg), Commercial ACE (1000 mg), Commercial Ibuprofen (IBU) (400 mg) - Dental Pain | Phase 2 | Completed | Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc. | 240 | 2014-12-31 | 2021-12-03 |
| Safety and Efficacy Study of NTC-510 to Treat Pain Following Dental Surgery of Third Molars NTC-510 capsules, Placebo Capsules, NTC-510A Capsules - Dental Pain | Phase 2 | Terminated | NanoSHIFT LLC | 52 | 2014-06-01 | 2017-06-23 |
| Study of Long-Acting Acetaminophen in Postoperative Dental Pain Acetaminophen ER, Placebo - Dental Pain | Phase 2 | Completed | McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. | 403 | 2013-10-01 | 2015-07-10 |
| Study of Naproxen Capsules to Treat Dental Pain Naproxen Test, Naprosyn, Placebo - Dental Pain | Phase 2 | Completed | Iroko Pharmaceuticals, LLC | 254 | 2010-10-01 | 2012-05-22 |
| Study of Diclofenac Capsules to Treat Dental Pain Diclofenac Test (lower dose), Diclofenac Test (upper dose), Celecoxib 400 mg - Dental Pain | Phase 2 | Completed | Iroko Pharmaceuticals, LLC | 202 | 2009-09-01 | 2012-05-22 |
| Safety and Efficacy Study of XPF-001 to Treat Pain Following Wisdom Tooth Extraction XPF-001, placebo - Dental Pain | Phase 2 | Completed | Xenon Pharmaceuticals Inc. | 61 | 2009-09-01 | 2012-07-16 |
| Study of Buprenorphine HCl Buccal Film in the Treatment of Dental Pain Oxycodone, Buprenorphine, Placebo Film - Dental Pain | Phase 2 | Completed | BioDelivery Sciences International | 153 | 2009-08-01 | 2017-02-27 |
| Phase 2 Study of Indomethacin Capsules to Treat Dental Pain Celecoxib 400 mg, Placebo, Indomethacin Test (lower dose) - Dental Pain | Phase 2 | Completed | Iroko Pharmaceuticals, LLC | 203 | 2009-08-01 | 2012-05-22 |
| Single Dose Study of N1539 in the Treatment of Pain Secondary to Dental Impaction Surgery N1539, placebo, Motrin - Dental Pain | Phase 2 | Completed | Alkermes, Inc. | 230 | 2009-07-01 | 2011-12-02 |
| A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction Placebo; oral, ARRY-371797, p38 inhibitor; oral, Celecoxib, COX-2 inhibitor; oral - Dental Pain | Phase 2 | Completed | Pfizer | 250 | 2008-04-07 | 2021-02-09 |
| A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction ARRY-371797, p38 inhibitor; oral, Placebo; oral - Dental Pain | Phase 2 | Completed | Pfizer | 103 | 2007-11-11 | 2021-02-21 |
| Maxi-Analgesic Phase 2 Study to Compare the Analgesic Effects in Different Dosing Groups to Treat Teeth Extraction Pain Full Dose Strength, Quarter dose strength, Half dose strength - Dental Pain | Phase 2 | Withdrawn | AFT Pharmaceuticals, Ltd. | 2013-07-12 |
Toothache (16) · Pain, Postoperative (3) · Agnosia (2) · Acute Pain (1) · Pain (1) · Patient Satisfaction (1)
Facial Pain (16) · Neurologic Manifestations (16) · Pathological Conditions, Signs and Symptoms (16) · Signs and Symptoms (16) · Stomatognathic Diseases (16) · Tooth Diseases (16) · Pain (15) · Pathologic Processes (3) · Postoperative Complications (3) · Nervous System Diseases (2) · Neurobehavioral Manifestations (2) · Perceptual Disorders (2) · Behavior (1) · Health Behavior (1) · Treatment Adherence and Compliance (1)
Acetaminophen (3) · Celecoxib (3) · ARRY-371797 (2) · Buprenorphine (2) · Ibuprofen (2) · Cyclooxygenase 2 Inhibitors (1) · Dental Atraumatic Restorative Treatment (1) · Meloxicam (1) · Naloxone (1) · Naproxen (1) · Oxycodone (1) · Papacarie (1) · Sugars (1)
Iroko Pharmaceuticals, LLC (3) · Nevakar, Inc. (2) · Pfizer (2) · AFT Pharmaceuticals, Ltd. (1) · Alkermes, Inc. (1) · BioDelivery Sciences International (1) · Cytogel Pharma, LLC (1) · Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc. (1) · McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. (1) · NanoSHIFT LLC (1) · Nourhan M.Aly (1) · Xenon Pharmaceuticals Inc. (1)
United States (15) · Egypt (1)
Steven Christensen, DDS (2) · David Blum, MD (1) · Eric Lang, MD (1) · Kenneth Somberg, MD (1) · May M Adham, M.Sc (1) · Michael Kuss, Doctor (1) · Mona K ElKashlan, PhD (1) · Todd Bertoch (1) · Wafaa E Abdelaziz, PhD (1) · William L Buchanan, MD,DDS (1)